|
|
|
Volumn 28, Issue 4, 1996, Pages 2207-2213
|
|
Long-term results of conversion from existing to microemulsion formulation of cyclosporine
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM ANTAGONIST;
CLONIDINE;
CYCLOSPORIN A;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
IMMUNOSUPPRESSIVE AGENT;
VASODILATOR AGENT;
ADULT;
AGED;
ANTIHYPERTENSIVE THERAPY;
CARDIOTOXICITY;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG BLOOD LEVEL;
DRUG FORMULATION;
DRUG SAFETY;
EMULSION;
FEMALE;
GRAFT REJECTION;
HUMAN;
HYPERTENSION;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY TRANSPLANTATION;
MAJOR CLINICAL STUDY;
MALE;
NEPHROTOXICITY;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
PRURITUS;
TREATMENT OUTCOME;
VERTIGO;
ADMINISTRATION, ORAL;
ADULT;
AGED;
BLOOD PRESSURE;
CREATININE;
CYCLOSPORINE;
DOSAGE FORMS;
EMULSIONS;
FEMALE;
FOLLOW-UP STUDIES;
GLOMERULAR FILTRATION RATE;
HEART RATE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
MALE;
MIDDLE AGED;
PROSPECTIVE STUDIES;
TIME FACTORS;
|
|
EID: 0029835513
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (6)
|
|
References (0)
|
